Strides Shasun receives nod from Drug Controller General of India for generic version of Sofosbuvir

Sofosbuvir is the first-in-class NSSB polymerase inhibitor to be launched in India for Hepatitis C treatment and represents a paradigm shift in the existing Hepatitis C cure.